Abstract:Chaperonins are biological nanomachines that help newly translated proteins to fold by rescuing them from kinetically trapped misfolded states. Protein folding assistance by the chaperonin machinery is obligatory in vivo for a subset of proteins in the bacterial proteome. Chaperonins are large oligomeric complexes, with unusual seven fold symmetry (group I) or eight/nine fold symmetry (group II), that form double-ring constructs, enclosing a central cavity that serves as the folding chamber. Dramatic large-scale conformational changes, that take place during ATP-driven cycles, allow chaperonins to bind misfolded proteins, encapsulate them into the expanded cavity and release them back into the cellular environment, regardless of whether they are folded or not. The theory associated with the iterative annealing mechanism, which incorporated the conformational free energy landscape description of protein folding, quantitatively explains most, if not all, the available data. Misfolded conformations are associated with low energy minima in a rugged energy landscape. Random disruptions of these low energy conformations result in higher free energy, less folded, conformations that can stochastically partition into the native state. Two distinct mechanisms of annealing action have been described. Group I chaperonins (GroEL homologues in eubacteria and endosymbiotic organelles), recognize a large number of misfolded proteins non-specifically and operate through highly coordinated cooperative motions. By contrast, the less well understood group II chaperonins (CCT in Eukarya and thermosome/TF55 in Archaea), assist a selected set of substrate proteins. Sequential conformational changes within a CCT ring are observed, perhaps promoting domain-by-domain substrate folding. Chaperonins are implicated in bacterial infection, autoimmune disease, as well as protein aggregation and degradation diseases. Understanding the chaperonin mechanism and the specific proteins they rescue during the cell cycle is important not only for the fundamental aspect of protein folding in the cellular environment, but also for effective therapeutic strategies.

Classification of Chemical Chaperones Based on Their Effect on Protein Folding Landscapes

Chemical chaperones: mechanisms of action and potential use

Mimicking Molecular Chaperones to Regulate Protein Folding

Small molecule pharmacological chaperones: From thermodynamic stabilization to pharmaceutical drugs

Chemical chaperones assist intracellular folding to buffer mutational variations

Pharmacological chaperones: a new twist on receptor folding

The therapeutic potential of chemical chaperones in protein folding diseases

Chaperone discovery

Chemical Chaperones Modulate the Formation of Metabolite Assemblies

Structural basis for the antifolding activity of a molecular chaperone

Enzymatic and synthetic regulation of polypeptide folding

Mechanisms of Chaperones As Active Assistant/Protector for Proteins: Insights from NMR Studies

Direct Observation of the Mechanical Role of Bacterial Chaperones in Protein Folding

Folding while bound to chaperones

Chaperones GroEL/GroES Accelerate the Refolding of a Multidomain Protein through Modulating On-pathway Intermediates

Molecular chaperones, evolution and medicine

Chemical and pharmacological chaperones as new therapeutic agents

Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers

Friends in need: How chaperonins recognize and remodel proteins that require folding assistance

Mechanism of chaperone coordination during cotranslational protein folding in bacteria